PharmaCyte Biotech (PMCB) EBITDA Margin (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly EBITDA Margin of 5547.89% for Q4 2012, down 351337.0% year-over-year from N/an in Q4 2011, and up 31.77% quarter-over-quarter from 8131.39% in Q3 2012.
PharmaCyte Biotech (PMCB) EBITDA Margin (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported EBITDA Margin for 3 consecutive years, with 5547.89% the latest figure, recorded in Q4 2012.
- In Q4 2012, EBITDA Margin fell 351337.0% year-over-year to 5547.89%; the TTM figure through Jul 2013 stood at 40488.52% (down 3705291.0% YoY), while the FY2013 annual figure was 13851.65%, down 1092311.0% from the prior year.
- EBITDA Margin grew to 5547.89% in Q4 2012 per PMCB's latest filing, from 8131.39% in the prior quarter.
- Across five years, EBITDA Margin topped out at 120.85% in Q4 2010 and bottomed at 8131.39% in Q3 2012.
- Historically, EBITDA Margin has averaged 2932.83% across 3 years, with a median of 2028.52% in 2011.
- On a YoY basis, EBITDA Margin climbed as much as 180774 bps in 2012 and fell as far as 679527 bps in 2012.
- PharmaCyte Biotech's EBITDA Margin stood at 120.85% in 2010, then plunged by 1583 bps to 2034.52% in 2011, then tumbled by 173 bps to 5547.89% in 2012.
- Business Quant data shows PMCB's EBITDA Margin at 5547.89% in Q4 2012, 8131.39% in Q3 2012, and 7227.51% in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | PharmaCyte Biotech | 4.30 Mn | 4.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -5,547.89% |
| Jul 31, 2012 | -8,131.39% |
| Apr 30, 2012 | -7,227.51% |
| Jan 31, 2012 | -2,022.51% |
| Oct 31, 2011 | -2,034.52% |
| Jul 31, 2011 | -3,302.30% |
| Apr 30, 2011 | -432.24% |
| Jan 31, 2011 | -214.77% |
| Oct 31, 2010 | -120.85% |
| Jul 31, 2010 | -294.27% |